mhurhangee/patent-ind-claim-en huggingface dataset:
Method for reproducing visual content data synchronously by a group of devices, the method comprising the steps of: - Determining a spatial location of each of the devices of the group , - Partitioning the visual content data into content parts, each content part dedicated to be reproduced by one device of the group respectively based on the spatial location of the device, wherein a distribution of the devices of the group is analyzed and the partitioning of the visual content is mapped to the distribution such that at least one feature of the visual content data to be reproduced is optimized, - Transmitting the dedicated content parts to their associated devices together with a time stamp, - Reproducing the transmitted portions commonly and synchronously by the group of devices, and characterized in that the at least one feature of the visual content data is computed based on histograms or cluster model of one or more of local structure frequency, brightness, luminance or colors of the visual content, and the optimization is performed towards cluster or histogram similarity such that less interesting areas in the visual content data are reproduced in regions of the distribution of the devices with a low density of devices. - Determining a spatial location of each of the devices of the group , - Partitioning the visual content data into content parts, each content part dedicated to be reproduced by one device of the group respectively based on the spatial location of the device, wherein a distribution of the devices of the group is analyzed and the partitioning of the visual content is mapped to the distribution such that at least one feature of the visual content data to be reproduced is optimized, - Transmitting the dedicated content parts to their associated devices together with a time stamp, - Reproducing the transmitted portions commonly and synchronously by the group of devices, and
A fiber-reinforced composite material , comprising a sensor array composed of a plurality of sensors for monitoring the structure of the composite material, electrical conductor tracks being incorporated into the composite material and extending through the composite material, the electrical conductor tracks being arranged in a first group and in a second group different from the first group, the electrical conductor tracks of the first group extending in a first direction, the electrical conductor tracks of the second group extending in a direction different from the first direction and intersecting the electrical conductor tracks of the first group, and thus, together with the conductor tracks of the first group, forming a network made of n row conductors and m column conductors , and a signal processing means for monitoring at least one electrical property of the conductor tracks being provided, whereby the structural state of the composite material can be determined, characterized in that a diode is arranged in each intersecting region of an electrical conductor track of the first group with an electrical conductor track of the second group, the connection between row conductors and column conductors being established by means of the diode so that a network in the form of a diode matrix is formed, the network being arranged in the form of a diode matrix by means of a dedicated carrier layer within the fiber-reinforced composite material , the carrier layer being a film.
A method for sensor-free determination of the orientation of the rotor of an ironless unslotted PMSM motor from a known rotor angle, comprising the steps: a. specifying a rotor system as the fixed-rotor coordinate system obtained by Park transformation according to the rotor angle; b. applying voltage pulses to the phases of the motor in the torque-forming direction of the rotor system; c. measuring the current in the phases of the motor; d. determining the expected back EMF along the flux-forming axis, based on the measured current; e. forming an integral of the expected back EMF by time integration of the expected back EMF along the flux-forming axis and/or forming a filter-based accumulation function; f. determining the orientation of the rotor from the algebraic sign of the integral of the expected back EMF along the flux-forming axis and/or the algebraic sign of the accumulation function. a. specifying a rotor system as the fixed-rotor coordinate system obtained by Park transformation according to the rotor angle; b. applying voltage pulses to the phases of the motor in the torque-forming direction of the rotor system; c. measuring the current in the phases of the motor; d. determining the expected back EMF along the flux-forming axis, based on the measured current; e. forming an integral of the expected back EMF by time integration of the expected back EMF along the flux-forming axis and/or forming a filter-based accumulation function; f. determining the orientation of the rotor from the algebraic sign of the integral of the expected back EMF along the flux-forming axis and/or the algebraic sign of the accumulation function.
A secondary battery module comprising a plurality of secondary batteries comprising an electrode assembly including an anode, a cathode, a separator and one or more through holes for sealing, a battery exterior member , and a passing sealing portion, characterized in that the passing sealing portion is formed by supplementary sealing the battery exterior member on the through holes formed on the electrode assembly , and a fixing bar is installed through the through holes formed in the plurality of the secondary batteries.
Bezel for motor vehicle glazing systems, comprising a base layer based on a thermoplastic, with a front side and a reverse side, and also sides connecting the front side and the reverse side, wherein the bezel has a coating on the front side and in the rounded edge region of the front side, characterized in that the edges between the sides connecting the front side and the reverse side of the base layer and the front side of the base layer have been rounded, wherein the rounding has a radius that is variable across the rounding.
A method for determining a concentration of at least one analyte in bodily fluid, the method comprising the following steps: - at least one signal generation step , wherein at least one excitation voltage signal is generated by at least one signal generator device , wherein the excitation voltage signal comprises at least one poly frequent alternating current (AC) voltage and at least one direct current (DC) voltage profile, wherein the poly frequent AC voltage comprises at least two frequencies; - at least one signal application step , wherein the excitation voltage signal is applied to at least two measurement electrodes , which are in contact with the bodily fluid and which are adapted to determine the analyte electrochemically; - at least one measurement step , wherein a response is measured by using the measurement electrodes ; - at least one evaluation step , wherein an AC current response for each frequency and a DC current response are evaluated from the response by at least one evaluation device , and wherein for each frequency at least one phase information and at least one impedance information is evaluated from the AC current response by the evaluation device ; - at least one determination step , wherein the concentration of the analyte is determined from the DC current response and from one or both of the phase information and impedance information by using at least one predetermined relationship, wherein the AC voltage and DC profile are superimposed to form the excitation voltage signal. - at least one signal generation step , wherein at least one excitation voltage signal is generated by at least one signal generator device , wherein the excitation voltage signal comprises at least one poly frequent alternating current (AC) voltage and at least one direct current (DC) voltage profile, wherein the poly frequent AC voltage comprises at least two frequencies; - at least one signal application step , wherein the excitation voltage signal is applied to at least two measurement electrodes , which are in contact with the bodily fluid and which are adapted to determine the analyte electrochemically; - at least one measurement step , wherein a response is measured by using the measurement electrodes ; - at least one evaluation step , wherein an AC current response for each frequency and a DC current response are evaluated from the response by at least one evaluation device , and wherein for each frequency at least one phase information and at least one impedance information is evaluated from the AC current response by the evaluation device ; - at least one determination step , wherein the concentration of the analyte is determined from the DC current response and from one or both of the phase information and impedance information by using at least one predetermined relationship,
A method for decoding control information by a User Equipment, UE, the method comprising: receiving a Physical Downlink Control Channel, PDCCH, from a base station; and decoding control information within a UE-specific search space of the PDCCH, wherein the UE-specific search space of the PDCCH has different locations among different UEs, and the UE determines the location of the UE-specific search space of the PDCCH by using a Radio Network Temporary Identifier, RNTI, of the UE, wherein the UE-specific search space of the PDCCH is defined for each of a plurality of subframes, each subframe including two slots, and wherein the UE determines the UE-specific search space of the PDCCH using a subframe index, wherein the UE decodes a set of PDCCH candidates within the UE-specific search space of the PDCCH during a subframe k when the PDCCH is received from the base station, and wherein each PDCCH candidate of the set of PDCCH candidates comprises a defined number of control channel elements, CCEs; wherein a Control Channel Element, CCE, corresponding to a specific PDCCH candidate among the set of PDCCH candidates is given by using Y k where Y k is defined by Y k = (A*Y k-1 ) mod D, and where A and D are 39827 and 65537, respectively, and Y- 1 is defined as the RNTI of the UE. receiving a Physical Downlink Control Channel, PDCCH, from a base station; and decoding control information within a UE-specific search space of the PDCCH,
A method for estimating a performance of a wireless communication network for a given time-frequency resource allocation, wherein said communications in said wireless communication network occur on a subset of time and frequency resources defined according to a frequency hopping sequence characterized in that said communications are subject to interferences whose activation is modeled by a binary random variable b t indicating whether an interferer is active or not at a time instant t, the discrete-time stochastic process { b t } t∈ [-∞;+∞] being modelled by a Markov chain with memory M on a finite space, M being a positive integer, said method comprising at least on iteration of: - Obtaining (S302), from a receiver, at least one set of consecutive observations of interference activation { b t-M , ..., b t } ; - Determining (S304) a frequency channel sequence { n f ( t - M ), ..., n f ( t )} associated with the at least one set of consecutive observations of interference activation { b t-M , ..., b t } from said frequency hopping sequence, where n f ( t ) is an index of a frequency channel used for communicating at time t ; - Identifying (S306) a Markov chain associated with the determined frequency channel sequence; - Updating (S308, S408) a set of probabilities of the identified Markov chain according to the obtained at least one set of consecutive observations of interference activation. - Obtaining (S302), from a receiver, at least one set of consecutive observations of interference activation { b t-M , ..., b t } ; - Determining (S304) a frequency channel sequence { n f ( t - M ), ..., n f ( t )} associated with the at least one set of consecutive observations of interference activation { b t-M , ..., b t } from said frequency hopping sequence, where n f ( t ) is an index of a frequency channel used for communicating at time t ; - Identifying (S306) a Markov chain associated with the determined frequency channel sequence; - Updating (S308, S408) a set of probabilities of the identified Markov chain according to the obtained at least one set of consecutive observations of interference activation.
A microcapsule comprising inorganic particle and benefit agent, wherein the microcapsule has a sphericity of 0.15 to 0.74, wherein: (a) said benefit agent is distributed throughout the particle, (b) said microcapsule is not core-shell microcapsule having a single core; and (c) said benefit agent comprises fragrance, pro-fragrance, organic sunscreen, skin lightening agent, anti-aging agent or a mixture thereof.
A bispecific molecule comprising at least one anti-CD38 domain and at least one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively, which bispecific molecule is a full length antibody comprising two heavy chains and four light chains, wherein each heavy chain comprises d. a Fc region comprising Hinge-CH2-CH3 domains, e. which Fc region is linked to Fab heavy chain (CH1-VH) of antibody 1 (Ab1), f. which in turn is linked to the Fab heavy chain (CH1-VH) of antibody 2 (Ab2), by a hinge-derived polypeptide linker sequence, wherein said polypeptide linker sequence links the N-terminus of said Fab heavy chain VH domain of Ab1 with the C-terminus of said CH1 domain of Ab2, and the four light chains comprise Fab light chains (CL-VL) of Ab1 and Fab light chains (CL-VL) of Ab2 associated with their cognate heavy chain domains; wherein Ab1 is atezolizumab and Ab2 is daratumumab. wherein each heavy chain comprises d. a Fc region comprising Hinge-CH2-CH3 domains, e. which Fc region is linked to Fab heavy chain (CH1-VH) of antibody 1 (Ab1), f. which in turn is linked to the Fab heavy chain (CH1-VH) of antibody 2 (Ab2), by a hinge-derived polypeptide linker sequence, wherein said polypeptide linker sequence links the N-terminus of said Fab heavy chain VH domain of Ab1 with the C-terminus of said CH1 domain of Ab2, d. a Fc region comprising Hinge-CH2-CH3 domains, e. which Fc region is linked to Fab heavy chain (CH1-VH) of antibody 1 (Ab1), f. which in turn is linked to the Fab heavy chain (CH1-VH) of antibody 2 (Ab2), by a hinge-derived polypeptide linker sequence, wherein said polypeptide linker sequence links the N-terminus of said Fab heavy chain VH domain of Ab1 with the C-terminus of said CH1 domain of Ab2, and the four light chains comprise Fab light chains (CL-VL) of Ab1 and Fab light chains (CL-VL) of Ab2 associated with their cognate heavy chain domains; wherein Ab1 is atezolizumab and Ab2 is daratumumab.
Unilaterally transparent laminated glass for an installation state in facades or an interior design, in particular laminated safety glass, comprising a first and a second glass pane and a laminating film composite which is arranged between the first and second glass panes and which is connected thereto and which has a first laminating film and a second laminating film , characterised in that - a large number of sequins having a first light-absorbing surface are arranged between the first laminating film and the second laminating film with an appearance (E) being achieved, wherein - the sequins with the light-absorbing surface face the first laminating film and are arranged spaced apart from each other in such a manner that the laminated glass when viewed from the light-absorbing surface of the sequins appears to be transparent, wherein a second surface of the sequins which faces the second laminating film is constructed to be light-reflecting, wherein the laminated glass when viewed from the light-reflecting surface of the sequins appears to be less transparent. - a large number of sequins having a first light-absorbing surface are arranged between the first laminating film and the second laminating film with an appearance (E) being achieved, wherein - the sequins with the light-absorbing surface face the first laminating film and are arranged spaced apart from each other in such a manner that the laminated glass when viewed from the light-absorbing surface of the sequins appears to be transparent,
A method of obtaining a three-dimensional composition comprising human inner ear sensory tissue, the method comprising the steps of: (a) culturing human induced pluripotent stem cell aggregates in a culture medium comprising FGF-2, BMP4 and a small molecule inhibitor of Transforming Growth Factor Beta (TGFβ) signaling for four days, wherein the small molecule inhibitor of TGFβ is SB431542; (b) further culturing the cultured aggregates of (a) in the presence of a Fibroblast Growth Factor (FGF) and a small molecule inhibitor of BMP signaling for 4 days, wherein the small molecule inhibitor of BMP is LDN-193189; (c) contacting the further cultured aggregates of (b) to a Wnt agonist for 4 days, wherein the Wnt agonist is an inhibitor of GSK3, whereby cells within the contacted aggregates differentiate into pre-otic epithelial cells; (d) embedding the pre-otic epithelial cells in a semi-solid culture medium comprising extracellular matrix protein and a basement membrane extract; (e) culturing the embedded pre-otic epithelial cells in the presence of a Wnt agonist for 6 days, wherein the Wnt agonist is an inhibitor of GSK3; and (f) culturing the embedded, pre-otic epithelial cells of (e) for at least a further 22-42 days under conditions that promote self-assembly of embedded pre-otic epithelial cells into otic vesicles , whereby a three-dimensional composition comprising human inner ear sensory tissue is obtained. (a) culturing human induced pluripotent stem cell aggregates in a culture medium comprising FGF-2, BMP4 and a small molecule inhibitor of Transforming Growth Factor Beta (TGFβ) signaling for four days, wherein the small molecule inhibitor of TGFβ is SB431542; (b) further culturing the cultured aggregates of (a) in the presence of a Fibroblast Growth Factor (FGF) and a small molecule inhibitor of BMP signaling for 4 days, wherein the small molecule inhibitor of BMP is LDN-193189; (c) contacting the further cultured aggregates of (b) to a Wnt agonist for 4 days, wherein the Wnt agonist is an inhibitor of GSK3, whereby cells within the contacted aggregates differentiate into pre-otic epithelial cells; (d) embedding the pre-otic epithelial cells in a semi-solid culture medium comprising extracellular matrix protein and a basement membrane extract; (e) culturing the embedded pre-otic epithelial cells in the presence of a Wnt agonist for 6 days, wherein the Wnt agonist is an inhibitor of GSK3; and (f) culturing the embedded, pre-otic epithelial cells of (e) for at least a further 22-42 days under conditions that promote self-assembly of embedded pre-otic epithelial cells into otic vesicles , whereby a three-dimensional composition comprising human inner ear sensory tissue is obtained.
A liquid dispensing device, comprising: a pressure chamber (660; 4970) and a dispensing head; said pressure chamber (660; 4970) comprising a pressure spring and a pressure piston (670; 4980; 6325); and said dispensing head comprising: a piston (630; 4940; 6313) and a piston chamber (17; 617; 4917; 6317), an outlet channel in fluid communication with the pressure chamber (660; 4970) and a piston chamber outlet; a piston chamber outlet valve (650; 4960; 6319) provided between said channel and said piston chamber outlet; and an outlet valve (610; 4920; 6305); characterized in that the piston chamber outlet valve (650; 4960; 6319) is arranged to be closed by fluid pressure in the pressure chamber (660; 4970). a pressure chamber (660; 4970) and a dispensing head; said pressure chamber (660; 4970) comprising a pressure spring and a pressure piston (670; 4980; 6325); and said dispensing head comprising: a piston (630; 4940; 6313) and a piston chamber (17; 617; 4917; 6317), an outlet channel in fluid communication with the pressure chamber (660; 4970) and a piston chamber outlet; a piston chamber outlet valve (650; 4960; 6319) provided between said channel and said piston chamber outlet; and an outlet valve (610; 4920; 6305); a piston (630; 4940; 6313) and a piston chamber (17; 617; 4917; 6317), an outlet channel in fluid communication with the pressure chamber (660; 4970) and a piston chamber outlet; a piston chamber outlet valve (650; 4960; 6319) provided between said channel and said piston chamber outlet; and an outlet valve (610; 4920; 6305); characterized in that the piston chamber outlet valve (650; 4960; 6319) is arranged to be closed by fluid pressure in the pressure chamber (660; 4970).
A capacitive voltage sensor comprising: a source electrode having an elongated shape that extends longitudinally along a longitudinal axis (Y), the source electrode including a first axial end portion and a second axial end portion opposite to the first axial end portion ; a tubular body having an elongated shape which extends longitudinally along the longitudinal axis (Y), the tubular body surrounding the source electrode and including a first axial portion and a second axial portion opposite to said first axial portion , the tubular body comprising: a support structure made of insulating material; a first layer of conductive material disposed on an outer surface of support structure , the first layer of conductive material configured as an electrical screen; a second layer of conductive material applied on an inner surface of the support structure , wherein the second layer of conductive material is configured to form an element for a capacitive coupling; and a mass of dielectric insulating material encompassing the source electrode and the tubular body . a source electrode having an elongated shape that extends longitudinally along a longitudinal axis (Y), the source electrode including a first axial end portion and a second axial end portion opposite to the first axial end portion ; a tubular body having an elongated shape which extends longitudinally along the longitudinal axis (Y), the tubular body surrounding the source electrode and including a first axial portion and a second axial portion opposite to said first axial portion , the tubular body comprising: a support structure made of insulating material; a first layer of conductive material disposed on an outer surface of support structure , the first layer of conductive material configured as an electrical screen; a second layer of conductive material applied on an inner surface of the support structure , wherein the second layer of conductive material is configured to form an element for a capacitive coupling; and a support structure made of insulating material; a first layer of conductive material disposed on an outer surface of support structure , the first layer of conductive material configured as an electrical screen; a second layer of conductive material applied on an inner surface of the support structure , wherein the second layer of conductive material is configured to form an element for a capacitive coupling; and a mass of dielectric insulating material encompassing the source electrode and the tubular body .
A process for the preparation of pimavanserin comprising: (i) providing an acid addition salt solution of pimavanserin in an organic solvent; (ii) washing the solution provided in step (i) with an alcohol/water/acid mixture; (iii) dissolving the acid addition salt of pimavanserin in an aqueous solvent to form an aqueous solution; (iv) washing the aqueous solution obtained in step (iii) with an organic solvent; (v) adding a base to the washed aqueous solution to form pimavanserin. (i) providing an acid addition salt solution of pimavanserin in an organic solvent; (ii) washing the solution provided in step (i) with an alcohol/water/acid mixture; (iii) dissolving the acid addition salt of pimavanserin in an aqueous solvent to form an aqueous solution; (iv) washing the aqueous solution obtained in step (iii) with an organic solvent; (v) adding a base to the washed aqueous solution to form pimavanserin.